← Evidence map

ArticleCytotherapy2022

Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): Study protocol for a phase 1 dose-escalation trial of patients with xerostomia after radiation therapy for head and neck cancer: MARSH: Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction.

Grace C Blitzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

12 papers cite it

2022
2023
2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 35183442